Dorothea Möslinger

1.2k total citations
31 papers, 572 citations indexed

About

Dorothea Möslinger is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Dorothea Möslinger has authored 31 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Clinical Biochemistry, 12 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Dorothea Möslinger's work include Metabolism and Genetic Disorders (19 papers), Mitochondrial Function and Pathology (8 papers) and Amino Acid Enzymes and Metabolism (5 papers). Dorothea Möslinger is often cited by papers focused on Metabolism and Genetic Disorders (19 papers), Mitochondrial Function and Pathology (8 papers) and Amino Acid Enzymes and Metabolism (5 papers). Dorothea Möslinger collaborates with scholars based in Austria, Switzerland and Germany. Dorothea Möslinger's co-authors include Sylvia Stöckler‐Ipsiroglu, Martina Huemer, Vassiliki Konstantopoulou, Adolf Mühl, Christian Huemer, Barbara Plecko, Chike Bellarmine Item, Michaela Brunner‐Krainz, Sabine Scholl‐Bürgi and Daniela Karall and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the Neurological Sciences and European Journal of Endocrinology.

In The Last Decade

Dorothea Möslinger

29 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorothea Möslinger Austria 14 358 274 177 133 98 31 572
Dimitar Gavrilov United States 15 437 1.2× 403 1.5× 345 1.9× 152 1.1× 200 2.0× 35 901
Coleman Turgeon United States 13 404 1.1× 380 1.4× 307 1.7× 132 1.0× 147 1.5× 26 821
Gülden Gökçay Türkiye 13 213 0.6× 277 1.0× 100 0.6× 78 0.6× 57 0.6× 30 492
Jun Ye China 15 305 0.9× 312 1.1× 127 0.7× 156 1.2× 105 1.1× 50 590
Alice Mazur United States 11 270 0.8× 164 0.6× 143 0.8× 66 0.5× 143 1.5× 13 570
Mercedes Martínez‐Pardo Spain 16 589 1.6× 559 2.0× 191 1.1× 165 1.2× 85 0.9× 35 782
Ubaldo Caruso Italy 15 338 0.9× 349 1.3× 136 0.8× 150 1.1× 108 1.1× 21 662
J. M. Saudubray France 18 615 1.7× 717 2.6× 164 0.9× 93 0.7× 100 1.0× 49 1.0k
John Fernandes Netherlands 11 205 0.6× 179 0.7× 164 0.9× 268 2.0× 71 0.7× 16 631
Maria Luı́s Cardoso Portugal 15 294 0.8× 257 0.9× 91 0.5× 89 0.7× 56 0.6× 29 542

Countries citing papers authored by Dorothea Möslinger

Since Specialization
Citations

This map shows the geographic impact of Dorothea Möslinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothea Möslinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothea Möslinger more than expected).

Fields of papers citing papers by Dorothea Möslinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothea Möslinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothea Möslinger. The network helps show where Dorothea Möslinger may publish in the future.

Co-authorship network of co-authors of Dorothea Möslinger

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothea Möslinger. A scholar is included among the top collaborators of Dorothea Möslinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothea Möslinger. Dorothea Möslinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werner, Helene, Markus A. Landolt, Andreas Hahn, et al.. (2024). Living with Pompe disease: results from a qualitative interview study with children and adolescents and their caregivers. Orphanet Journal of Rare Diseases. 19(1). 358–358.
2.
Beghini, Marianna, Maximilian Pichler, Dorothea Möslinger, et al.. (2024). Poor adherence during adolescence is a risk factor for becoming lost-to-follow-up in patients with phenylketonuria. Molecular Genetics and Metabolism Reports. 39. 101087–101087. 3 indexed citations
3.
Werner, Helene, Markus A. Landolt, Andreas Hahn, et al.. (2024). The PompeQoL questionnaire: Development and validation of a new measure for children and adolescents with Pompe disease. Journal of Inherited Metabolic Disease. 47(6). 1348–1362. 1 indexed citations
4.
Demirbas, Didem, Alberto Burlina, Ana Chiesa, et al.. (2022). Galactose epimerase deficiency: lessons from the GalNet registry. Orphanet Journal of Rare Diseases. 17(1). 331–331.
5.
Herle, Marion, Michaela Brunner‐Krainz, Daniela Karall, et al.. (2021). A retrospective study on disease management in children and adolescents with phenylketonuria during the Covid-19 pandemic lockdown in Austria. Orphanet Journal of Rare Diseases. 16(1). 367–367. 4 indexed citations
6.
Beghini, Marianna, Dorothea Möslinger, Vassiliki Konstantopoulou, et al.. (2021). Project “Backtoclinic I”: An overview on the state of care of adult PKU patients in Austria. Molecular Genetics and Metabolism. 133(3). 257–260. 9 indexed citations
7.
Löscher, Wolfgang N., Martina Huemer, Thomas M. Stulnig, et al.. (2017). Pompe disease in Austria: clinical, genetic and epidemiological aspects. Journal of Neurology. 265(1). 159–164. 27 indexed citations
8.
Rommer, Paulus, Johannes Zschocke, Brian Fowler, et al.. (2017). Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency. Journal of the Neurological Sciences. 383. 123–127. 8 indexed citations
9.
Item, Chike Bellarmine, et al.. (2016). Demethylation of the promoter region of GPX3 in a newborn with classical phenylketonuria. Clinical Biochemistry. 50(3). 159–161. 7 indexed citations
10.
Karall, Daniela, Michaela Brunner‐Krainz, Vassiliki Konstantopoulou, et al.. (2015). Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD). Orphanet Journal of Rare Diseases. 10(1). 21–21. 43 indexed citations
11.
Hu, Liyan, Amit V. Pandey, Véronique Rüfenacht, et al.. (2013). Understanding the Role of Argininosuccinate Lyase Transcript Variants in the Clinical and Biochemical Variability of the Urea Cycle Disorder Argininosuccinic Aciduria. Journal of Biological Chemistry. 288(48). 34599–34611. 9 indexed citations
12.
Paschke, Eduard, Johannes Zschocke, Michaela Brunner‐Krainz, et al.. (2012). Prevalence of tetrahydrobiopterine (BH4)‐responsive alleles among Austrian patients with PAH deficiency: comprehensive results from molecular analysis in 147 patients. Journal of Inherited Metabolic Disease. 36(1). 7–13. 18 indexed citations
13.
Kasper, David C., Rene Ratschmann, Thomas P. Mechtler, et al.. (2010). The National Austrian Newborn Screening Program – Eight years experience with mass spectrometry. Past, present, and future goals. Wiener klinische Wochenschrift. 122(21-22). 607–613. 51 indexed citations
14.
Haberlandt, Edda, Michaela Brunner‐Krainz, Dorothea Möslinger, et al.. (2009). Epilepsy in Patients with Propionic Acidemia. Neuropediatrics. 40(3). 120–125. 25 indexed citations
15.
Huemer, Martina, Manuela Födinger, Olaf A. Bodamer, et al.. (2008). Total homocysteine, B-vitamins and genetic polymorphisms in patients with classical phenylketonuria. Molecular Genetics and Metabolism. 94(1). 46–51. 17 indexed citations
16.
Ipsiroglu, O., Marion Herle, Dorothea Möslinger, et al.. (2005). Transcultural pediatrics: Compliance and outcome of phenylketonuria patients from families with an immigration background. Wiener klinische Wochenschrift. 117(15-16). 541–547. 12 indexed citations
17.
Votava, Felix, Dóra Török, József Kovács, et al.. (2005). Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia. European Journal of Endocrinology. 152(6). 869–874. 44 indexed citations
18.
Mühl, Adolf, et al.. (2001). Molecular characterisation of 34 patients with biotinidase deficiency ascertained by newborn screening and family investigation. European Journal of Human Genetics. 9(4). 237–243. 28 indexed citations
19.
Möslinger, Dorothea, Sylvia Stöckler‐Ipsiroglu, S Scheibenreiter, et al.. (2001). Clinical and neuropsychological outcome in 33 patients with biotinidase deficiency ascertained by nationwide newborn screening and family studies in Austria. European Journal of Pediatrics. 160(5). 277–282. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitar Gavrilov Breakdown of academic impact, for papers by Coleman Turgeon Breakdown of academic impact, for papers by Gülden Gökçay Breakdown of academic impact, for papers by Jun Ye Breakdown of academic impact, for papers by Alice Mazur Breakdown of academic impact, for papers by Mercedes Martínez‐Pardo Breakdown of academic impact, for papers by Ubaldo Caruso Breakdown of academic impact, for papers by J. M. Saudubray Breakdown of academic impact, for papers by John Fernandes Breakdown of academic impact, for papers by Maria Luı́s Cardoso
Rankless by CCL
2026